Cooper Companies Inc (COO) Shares Sold by Wedbush Securities Inc.
Wedbush Securities Inc. cut its holdings in shares of Cooper Companies Inc (NYSE:COO) by 10.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,640 shares of the medical device company’s stock after selling 185 shares during the quarter. Wedbush Securities Inc.’s holdings in Cooper Companies were worth $486,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Essex Savings Bank acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $25,000. Certified Advisory Corp acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $25,000. Executive Wealth Management LLC acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $34,000. Financial Gravity Companies Inc. acquired a new position in shares of Cooper Companies during the fourth quarter worth approximately $46,000. Finally, Rehmann Capital Advisory Group lifted its holdings in shares of Cooper Companies by 24.3% during the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock worth $56,000 after buying an additional 43 shares during the last quarter.
In other Cooper Companies news, Director Gary S. Petersmeyer sold 799 shares of the company’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $286.88, for a total value of $229,217.12. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Agostino Ricupati sold 2,400 shares of the company’s stock in a transaction on Friday, March 29th. The shares were sold at an average price of $296.13, for a total value of $710,712.00. Following the completion of the sale, the senior vice president now owns 400 shares in the company, valued at $118,452. The disclosure for this sale can be found here. Insiders sold 87,030 shares of company stock valued at $25,461,465 over the last 90 days. 1.70% of the stock is currently owned by corporate insiders.
Shares of NYSE COO opened at $284.31 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.27 and a quick ratio of 0.75. The firm has a market capitalization of $14.09 billion, a P/E ratio of 24.72, a PEG ratio of 2.18 and a beta of 0.88. Cooper Companies Inc has a one year low of $220.90 and a one year high of $302.36.
Cooper Companies (NYSE:COO) last issued its earnings results on Tuesday, March 5th. The medical device company reported $2.88 EPS for the quarter, beating analysts’ consensus estimates of $2.50 by $0.38. The business had revenue of $628.10 million during the quarter, compared to analyst estimates of $618.50 million. Cooper Companies had a return on equity of 17.56% and a net margin of 14.22%. Equities analysts anticipate that Cooper Companies Inc will post 12.01 EPS for the current year.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Recommended Story: Liquidity
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.